Abstract
Systemic mycoses are life-threatening infections in granulocytopenic patients with neoplastic diseases (Horn et al. 1985; Walsh and Pizzo 1988). The problems of nosocomial outbreaks, clinical resistance, microbiological resistance, emergence of new pathogens, and difficulty in establishing an early diagnosis present formidable challenges to the successful management of these patients. Progress in treating these infections is being achieved through greater understanding of established available antifungal agents such as amphotericin B, flucytosine, miconazole, and ketoconazole. Promising investigational agents such as fluconazole and intraconazole will require careful clinical investigation in order to define their role in granulocytopenic patients. This chapter will review the management of fungal infections in granulocytopenic patients with neoplastic diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adam RD, Paquin ML, Petersen EA, Sauballe MA, Rinaldi MG (1986) Phaeohyphomycosis caused by the fungal genera Bipolaris and Exserohilum. A report of 9 cases and review of the literature. Medicine 65: 203–217
Adamson P, Rinaldi MG, Pizzo PA, Walsh TJ (1990) Amphotericin B in the treatment of Candida cholecystitis. Rev Infect Digest (in press)
Aisner J, Schimpff SC, Bennett JE, Young VM, Wiernik PH (1976) Aspergillus infections in cancer patients: association with fireproofing materials in a new hospital. JAMA 235: 411–412
Allo MD, Miller J, Townsend T, Tan C (1987) Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 317: 1105–1108
Anaissie EA, Hoy J, Jones P, Rolston K, Bodey GP (1985) New fungal pathogens in immunocompromised patients. 25th Intersci Conf Antimicrob Agents Chemother, Minneapolis, Abstr 870, p 253
Aoki S, Walsh TJ, Mechinaud F, Rubin M, Pizzo PA (1987) Effects of granulocytopenia and antifungal therapy in an experimental rabbit model of Candida endophthalmitis. 27th Intersci Conf Antimicrob Agents Chemother, New York, Abstr 775, p 232
Armstrong DA (1984) Protected environments are discomforting and expensive and do not offer meaningful protection. Am J Med 76: 685–689
Bennett JE (1987) Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 9: 398–402
Bodey GP (1984) Current status of prophylaxis of infection with protected environments. Am J Med 76: 678–684
Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK (1987) Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 5: 1985–1993
Chaulk CP, Smith PW, Feagler JR, Verdirame J, Commers JR (1986) Fungemia due to Fusarium solani in an immunocompromised child. Pediatr Infect Dis 5: 363–366
Commers J, Robichaud KJ, Pizzo PA (1984) New pulmonary infiltrates in granulocytopenic patients being treated with antibiotics. Pediatr Infect Dis 3: 423–428
De Repentigny L, Reiss E (1984) Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis 6: 301–312
Deresinski SC, Stevens DA (1977) Coccidioidomycosis in compromised hosts. Medicine 54: 377–395
Dick JD, Merz WC, Sarai R (1980) Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 18: 158–163
Dick JD, Rosengard BR, Merz WG, Stuart RK, Hutchins GM, Sarai R (1985) Fatal disseminated candidiasis due to amphotericin B resistant Candida guilliermondii. Ann Int Med 102: 67–68
Dixon DM, Polak A, Walsh TJ (1988) Phaeaohyphomycosis. In: Torres-Rodriguez JM (ed) Proceedings of the X congress of the international society for human and animal mycology(-ISHAM). JR Prous, Barcelona, pp 84–92
Drutz DJ (1983) Amphotericin B in the treatment of coccidioidomycosis. Drugs 26: 337–346
Edwards JE, Lehrer RI, Stiehm ER, Fischer TJ, Young LS (1978) Severe candidal infections. Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med 89: 91–106
England AC, Weinstein M, Ellner JJ, Ajello L (1981) Two cases of rhinocerebral zygomycosis (mucormycosis) with common epidemiologic and environmental features. Am Rev Respir Dis 124: 497–498
Everett ED, Pearson S, Rogers W (1979) Rhizopus surgical wound infection associated with elasticized adhesive tape dressings. Arch Surg 114: 738–739
Gartenberg G, Bottone EJ, Keusch GT, Weitzman (1987) Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue. N Engl J Med 299: 1115–1118
Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ (1984) Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Int Med 100: 345–351
Glatt AE, Chirgwin K, Landesman SH (1988) Current concepts: treatment of infections asociated with human immunodeficiency virus. N Engl J Med 318: 1439–1448
Grant IH, Armstrong D (1988) Fungal infections in AIDS. Cryptococcosis. Infect Dis Clin NA 2: 457–464
Helton WS, Carrico CJ, Zaveruha PA, Schaller R (1986) Diagnosis and treatment of splenic fungal abscesses in the immunosuppressed patient. Arch Surg 121: 580–586
Henderson DK, Hockley LJ, Vukalcic LJ, Edwards JE (1980) Effect of immunosuppression on the development of experimental hematogenous Candida endophthalmitis. Infect Immun 27: 628–631
Henry NK, McLimans CA, Wright AJ, Thompson RL, Wilson WR, Washington JA (1983) Microbiologic and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol 17: 864–869
Holleran WM, Wilbur JR, DeGregorio MW (1985) Empiric amphotericin B therapy in patients with acute leukemia. Rev Infect Dis 7: 619–624
Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis 7: 646–655
Jarowski CI, Fialk MA, Murray HW, Gottlieb GJ, Coleman M, Steinberg CR, Silver RT (1978) Fever, rash, and muscle tenderness. Arch Int Med 138: 544–546
Johnson JD, Raff MJ (1984) Fungal splenic abscess. arch Int Med 144: 1987–1993
June CH, Beatty PG, Schulman HM, Rinaldi MG (1986) Disseminated Fusarium moniliforme infection after allogeneic marrow transplantation. S Med J 79: 513–515
Kiehn TE, Wong B, Edwards EF, Armstrong D (1983) Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol 18: 300–304
Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D (1985) Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol 21: 501–504
Klein JJ, Watanakunakorn C (1979) Hospital-acquired fungemia: its natural course and clinical significance. Am J Med 67: 51–58
Krasinski K, Holzman RS, Hanna B, Greco MA, Graff M, Bhogal M (1985) Nosocomial fungal infection during hospital renovation. Infect Control 6: 278–282
Kwon-Chung KJ, Young RC, Orlando MV (1975) Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Pathol 64: 544–548
Lehrer RI, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ (1980) Mucormycosis. Ann Int Med 93: 93–108
Lopez-Berestein G, Bodey GP, Frankel LS, Menta K (1987) Treatment of hepatosplenic candidiasis with liposomal amphotericin B. J Clin Oncol 5: 310–317
Lutwick LI, Rytel MW, Yanez JP, Galgiani JN, Stevens DA (1979) Deep infections from Petriellidium boydii treated with miconazole. JAMA 241: 272–273
Mahoney DH, Steuber CP, Starling KA, Barrett FF, Goldberg J, Fernbach DJ (1979) An outbreak of aspergillosis in children with acute leukemia. J Pediatr 95: 70–72
Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP (1984) Systemic candidiasis in cancer patients. Am J Med 77: 20–27
Merz WG, Karp JE, Schron D, Sarai R (1986) Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 24: 581–584
Meunier F, Leleux A, Gerain J, Ninove D, Snoeck R, Klastersky J (1987) Prophylaxis of aspergillosis in neutropenic cancer patients with nasal spray of amphotericin B: a prospective randomized study. 27th Intersci Conf Antimicrob Agents Chemother, New York, Abstr 1346, p 331
Meyer RD, Rosen P, Armstrong D (1972) Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 77: 871–879
Meyer RD, Young LS, Armstrong D, Yu B (1973) Aspergillosis complicating neoplastic disease. Am J Med 54: 6–15
Minamoto G, Armstrong D (1988) Fungal infections in AIDS. Histoplasmosis and coccidioidomycosis. Infect Dis Clin NA 2: 447–456
Montgomerie JZ, Edwards JE (1978) Association of infection due to Candida albicans with intravenous hyperalimentation. J Infect Dis 137: 197–201
Opal SM, Asp AA, Cannady PB, Morse PL, Burton LJ, Hammer PG (1986) Effect of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis 153: 634–637
Panos RJ, Barr LF, Walsh TJ, Silverman HJ (1988) Factors associated with fatal hemoptysis in cancer patients. Chest 94: 1008–1013
Pappagianis D, Collins MS, Hector R, Remington J (1979) Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 16:123–126
Peterson PK, McGlave P, Ramsay NKC, Rhame F, Cohen E, Perry GS, Goldman AI, Kersey J (1983) A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and cytomegalovirus as the major causes of mortality. Infect Control 4: 81–89
Pizzo PA, Robichaud KJ, Gill FA, Witebsky F (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 72: 101–110
Pizzo PA, Hathorn JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McNight J, Ribin M, Skelton J, Thaler M, Wesley R (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315: 552–558
Plouffe JF, Brown DG, Silva J Jr, Eck T, Stricof RL, Fekety R (1977) Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Int Med 137: 1686–1689
Powderly WG, Kobayashi GS, Herzig GP, Medoff G (1988) Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 84: 826–832
Prystowsky SD, Vogelstein B, Ettinger DS, Merz WG, Kaizer H, Sulica VI, Zinkham WH (1976) Invasive aspergillosis. N Engl J Med 295: 655–658
Redline RW, Redline SS, Roxenbaum B, Dahms BB (1985) Systemic Malassezia furfur infection in patients receiving intralipid therapy. Hum Pathol 16: 815–822
Rhame FS (1985) Lessons from the Roswell Park bone marrow transplant aspergillosis outbreak. Infect Control 6: 345–346
Rippon JW (1988) Pseudallescheriasis. In: Rippon JW (ed) Medical mycology, 3rd edn. Saunders, Philadelphia, pp 651–680
Rogers TR (1986) Infections in hematologic malignancy. Infect Control 7: 140–142
Rose HD (1978) Venous catheter-associated candidemia. Am J Med Sci 275: 265–270
Rosen PP, Sternberg SS (1976) Decreased frequency of aspergillosis and mucormycosis. N Engl J Med 295: 1319–1320
Rotstein C, Cummings KM, Tidings J, Killion K, Powell E, Gustafson TL, Higby D (1985) An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case control study. Infect Control 6: 347–355
Schaffner A, Davis CE, Schaffner T, Markert M, Douglas H, Braude AI (1986) In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J Clin Invest 78: 511–524
Sheldon DL, Johnson WC (1979) Cutaneous mucormycosis. Two documented cases of suspected nosocomial cause. JAMA 241: 1032–1034
Smith AG, Crain SM, Dejongh C, Thomas GM, Vigorito RD (1985) Systemic pseudallescheriasis in a patient with acute myelocytic leukemia. Mycopathologia 90: 85–89
Solomon SL, Khabbaz RF, Parker RH, Anderson RL, Geraghty MA, Furman RM, Martone WJ (1984) An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 149: 98–107
Solomon SL, Alexander H, Eley JW, Anderson RL, Goodpasture HC, Smart S, Furman RM, Martone WJ (1986) Nosocomial fungemia in neonates associated with intravascular pressure monitoring devices. Pediatr Infect Dis J 5: 680–685
Thaler M, Pastakia B, Shawker TH, O’Leary TO, Pizzo PA (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Int Med 108: 88–100
Turner RB, Donowitz LG, Hendley JO (1985) Consequences of candidemia for pediatric patients. Am J Dis Child 139: 178–180
Viollier A-F, Peterson DE, De Jongh CA, Newman KA, Gray WC, Sutherland JC, Moody MA, Schimpff SC (1986) Aspergillus sinusitis in cancer patients. Cancer 58: 366–371
Walsh TJ, Gray W (1987) Candida epiglottitis in immunocompromised patients. Chest 91: 482–485
Walsh TJ, Merz WG (1986) Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol 85: 498–502
Walsh TJ, Pizzo PA (1988) Nosocomial fungal infections: a classification for hospital-acquired fungal infections mycoses arising from endogenous flora or reactivation. Ann Rev Microbiol 42: 517–545
Walsh TJ, Catchatourian R, Cohen H (1983) Disseminated histoplasmosis complicating bone marrow transplantation. Am J Clin Pathol 79: 509–511
Walsh TJ, Caplan LR, Hier DB (1985) Aspergillus infections of the central nervous system: a clinicopathologic analysis. Ann Neurol 18: 574–582
Walsh TJ, Bustamente CI, Vlahov D, Standiford HC (1986a) Candidal suppurative peripheral thrombophlebitis, recognition, prevention, and management. Infect Control 7: 16–22
Walsh TJ, Newman KR, Moody M, Wharton RC, Wade JC (1986b) Trichosporonosis in patients with neoplastic disease. Medicine 65: 268–279
Walsh TJ, Hamilton SR, Belitsos N (1988) Esophageal candidiasis. Diagnosis and treatment of an increasingly recognized fungal infection. Postgrad Med 84: 193–205
Weems JJ, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL (1987) Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 25: 1029–1032
Wingard JR, Merz WG, Sarai R (1979) Candida tropicalis: a major pathogen in immunocompromised patients. Ann Int Med 91: 539–543
Wingard JR, Dick JD, Merz WG, Sanford GR, Sarai R, Burns WH (1980) Pathogenecity of C. tropicalis and C. albicans after gastrointestinal inoculation in mice. Infect Immun 29: 808–813
Yu VL, Müder RR, Poorsattar A (1986) Significance of isolation of Aspergillus from the respiratory tract in the diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 81: 249–254
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Walsh, T.J., Pizzo, P.A. (1990). Management of Fungal Infections in Patients with Neoplastic Diseases. In: Ryley, J.F. (eds) Chemotherapy of Fungal Diseases. Handbook of Experimental Pharmacology, vol 96. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75458-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-75458-6_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75460-9
Online ISBN: 978-3-642-75458-6
eBook Packages: Springer Book Archive